v2.3.0.11
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands
 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Operating activities    
Net income $ 2,260 $ 965
Adjustments to reconcile net income to net cash provided by operating activities:    
Share-based compensation expense related to stock options and employee stock purchase plan 2,795 2,996
Excess tax benefit from exercise of stock options (463) (500)
Amortization of other purchased intangibles 1,265 1,388
Amortization of debt issuance cost 144 143
Depreciation 1,050 948
Change in valuation allowance on deferred tax assets 89 (1,652)
Impairment of intangible assets 1,681  
Accretion/amortization on short-term debt securities (408) 89
Realized gain on Auction Rate Securities (ARS)   (1,032)
Unrealized (gain)/loss on ARS   80
Realized loss on fair value of put option   1,032
Unrealized (gain)/loss on fair value of put option   (93)
Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:    
Accounts receivable, net of allowance 3,948 14,935
Other current assets (213) 3,201
Accounts payable 87 (950)
Accrued compensation (863) (371)
Other accrued liabilities 406 (3,161)
Deferred tax assets, net of liabilities 111 331
Income taxes receivable (776) 333
Income taxes payable (1,877) (789)
Other deferred liabilities (208) (184)
Restructuring liabilities (977) (872)
Deferred revenue (234) (4,777)
Net cash provided by operating activities 7,817 12,060
Investing activities    
Purchases of property and equipment (341) (462)
Proceeds from sale and maturity of investments 57,365 12,588
Purchases of short-term investments (20,057) (15,274)
Acquisition of Xenos Group Inc., net of cash acquired   (27,343)
Proceeds from security deposits and other 92 (237)
Net cash provided by (used in) investing activities 37,059 (30,728)
Financing activities    
Repayment of long term debt (40,000)  
Proceeds from the Credit Facility, net of issuance cost   9,986
Excess tax benefit from exercise of stock options 463 500
Proceeds from issuance of common stock 5,158 2,960
Stock repurchases   (9,999)
Net cash provided by (used in) financing activities (34,379) 3,447
Effect of exchange rates on cash and cash equivalents 2,014 (496)
Net increase/(decrease) in cash and cash equivalents 12,511 (15,717)
Cash and cash equivalents at the beginning of the period 33,269 53,173
Cash and cash equivalents at the end of the period $ 45,780 $ 37,456